Publikationen 2007

hGH-abuse in athletes.

Strasburger CJ, Wu Z, Bidlingmaier M.

Ann Endocrinol (Paris). 2007 Sep;68(4):306-7

Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols.

Gruendel S, Garcia AL, Otto B, Wagner K, Bidlingmaier M, Burget L, Weickert MO, Dongowski G, Speth M, Katz N, Koebnick C.

Br J Nutr. 2007 Dec;98(6):1170-7. Epub 2007 Jul 19.

Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys.

Kurnik K, Kreuz W, Horneff S, Düring C, Schobess R, Bidlingmaier C, Ettingshausen CE, Krümpel A, Bogdanova N, Nowak-Göttl U.

Haematologica. 2007 Jul;92(7):982-5.

Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects.

Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE.

J Clin Endocrinol Metab. 2007 Sep;92(9):3374-7. Epub 2007 Jun 26.

Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration.

Keller A, Wu Z, Kratzsch J, Keller E, Blum WF, Kniess A, Preiss R, Teichert J, Strasburger CJ, Bidlingmaier M.

Eur J Endocrinol. 2007 Jun;156(6):647-53.

Role of placental growth hormone in the alteration of maternal arterial resistance in pregnancy.

Schiessl B, Strasburger CJ, Bidlingmaier M, Gutt B, Kirk SE, Oberhoffer R, Friese K.

J Reprod Med. 2007 Apr;52(4):313-6.

Growth hormone assays: current methodologies and their limitations.

Bidlingmaier M, Strasburger CJ.

Pituitary. 2007;10(2):115-9. Review.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.

Müssig K, Gallwitz B, Honegger J, Strasburger CJ, Bidlingmaier M, Machicao F, Bornemann A, Ranke MB, Häring HU, Petersenn S.

Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):198-202.

Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.

Fainstein Day P, Frohman L, Garcia Rivello H, Reubi JC, Sevlever G, Glerean M, Fernandez Gianotti T, Pietrani M, Rabadan A, Racioppi S, Bidlingmaier M.

Pituitary. 2007;10(3):311-9.

What endocrinologists should know about growth hormone measurements.

Bidlingmaier M, Strasburger CJ.

Endocrinol Metab Clin North Am. 2007 Mar;36(1):101-8. Review.

The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis.

Murray RD, Bidlingmaier M, Strasburger CJ, Shalet SM.

J Clin Endocrinol Metab. 2007 May;92(5):1705-9. Epub 2007 Feb 27.

Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly.

Morrison KM, Bidlingmaier M, Stadler S, Wu Z, Skriver L, Strasburger CJ.

Eur J Endocrinol. 2007 Mar;156(3):331-9.

Preanalytical stability of adrenocorticotropic hormone depends on time to centrifugation rather than temperature.

Reisch N, Reincke M, Bidlingmaier M.

Clin Chem. 2007 Feb;53(2):358-9

Diagnosis of primary hyperaldosteronism

Diederich S, Bidlingmaier M, Quinkler M, Reincke M.

Med Klin (Munich). 2007 Jan 15;102(1):